APTN

distress 6/10 · elevated risk

$6.25+0%today0% from 52w high

adaptinbio.com4 employeesFounded 2021Charlotte, NC

Revenue

pre-revenue

Liquidity

$0M

Runway

0.1 yrs

Shares 1y

+5%

Price & events

+11.6% over 6M

CatalystRating changeDilutionFinancingdashed = today

+0.5%

+1.1%

—

+11.6%

All

Overview

Market Cap: $55.65M
Volume: 568
52 Week Range: $5.60 – $6.25
Total Shares: 8.90M
Float Shares: 2.61M
% Held by Insiders: 71.19%
% Held by Institutions: 0.00%
RVOL: 2.14x

Pipeline · 0 trials · 0 upcoming

Readout	Phase	Drug	Indication	Enroll	Status
No pipeline trials tracked.

Catalyst news & presentations · 0

No catalyst news yet.

Approved drugs (0)

none — clinical-stage

Capital structure — dilution & financing

Shares out: 8,903,229 · 6 offerings/1y · 1 PIPEs

2026-07-22EFFECTshelf_effective
2026-06-12424B3offering
2026-05-18424B3offering
2025-12-238-Kprivate_placement
2025-11-17424B3offering
2025-10-07424B3offering
2025-08-15424B3offering

🔒 Positioning — Pro

Short interest / days-to-cover, insider buys & sells.

Upgrade to Pro

🔒 Top holders — Pro

Institutional ownership + quarter-over-quarter accumulation/trimming.

Upgrade to Pro

Wall St ratings

no consensus

no recent rating changes

Competitors

none identified